一种mRNA疫苗编码了五种保存的A组链球菌抗原
Nichaela Harbison-Price1, Ismail Sebina2, Rhiannon A Bolton2
1Centre for Superbug Solutions, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia.
Nature communications
|July 1, 2025
概括
使者RNA (mRNA) 脂质纳米粒子 (LNP) 疫苗显示出对抗A组链球菌 (GAS) 感染的前景. 这项研究表明,mRNA-LNP疫苗有效地保护小鼠,并引起强大的免疫反应,突出了该平台.
科学领域:
- 疫苗学 疫苗学 疫苗学
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
背景情况:
- 甲型链球菌 (GAS) 导致全球疾病负担显著,需要新的疫苗策略.
- 使者RNA (mRNA) 脂质纳米粒子 (LNP) 技术为开发针对细菌病原体的疫苗提供了一个新的平台.
研究的目的:
- 评估多组分mRNA-LNP疫苗 (Combo#5) 对GAS的免疫性和临床前疗效.
- 在小鼠模型中评估接种疫苗后的免疫细胞反应和抗体产生.
主要方法:
- 开发了一种针对GAS的多组分mRNA-LNP疫苗配方 (Combo#5) .
- 在腹腔内和皮下模型中给小鼠注射疫苗并用GAS挑战它们.
- 分析了免疫细胞群 (CD4 +,CD8 + T 细胞,T 毛囊辅助细胞,B 细胞) 和抗原特异性抗体水平.
主要成果:
- 组合#5mRNA-LNP疫苗接种在小鼠挑战模型中提供了对GAS感染的保护.
- 接种疫苗显著增加了 CD4 + 和 CD8 + T 细胞频率和数量.
- 观察到增强的T卵泡辅助细胞,生殖中心B细胞,记忆B细胞和抗原特异性抗体生产.
结论:
- 该mRNA-LNP平台展示了开发针对GAS.LNP等细菌病原体的有效疫苗的潜力.
- 组合#5mRNA-LNP疫苗配方在临床前模型中具有免疫性和有效性.
- 这项研究支持进一步开发针对传染病的mRNA-LNP疫苗.
相关概念视频
Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Bacterial Meningitis
Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Streptococcal Pharyngitis
Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Bacterial Meningitis I: Introduction
Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...


